What is a Loan Licence in the Pharmaceutical Industry

What is a Loan Licence in the Pharmaceutical Industry

If you are planning to manufacture pharmaceutical products without setting up your own factory, a loan licence in the pharmaceutical industry is likely the route you need. This guide explains what the licence means, who should apply for it, the documents involved, and the step-by-step process to get one in India.

What is a Loan Licence

A loan licence allows a pharmaceutical company to manufacture drugs using another company's licensed manufacturing facility instead of building its own. The licence holder, known as the loan licensee, does not own the factory but is legally permitted to produce and market drugs under their own brand name through the licensor's premises. This arrangement is regulated under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, and is issued by the State Drug Controller of the state where the manufacturing unit is located.

Why It Matters and Who Needs It

Setting up a full-scale pharmaceutical manufacturing plant requires heavy capital investment in machinery, clean rooms, and quality control labs. A loan licence lets entrepreneurs and smaller pharma companies enter the market without that upfront cost. It suits businesses that want to launch their own drug brands, test market demand before investing in infrastructure, or scale production using an established manufacturer's capacity. Many new pharma marketing companies in India start this way before eventually building their own units.

Documents and Eligibility Requirements

Before applying for a loan licence, keep the following documents and eligibility points ready:

• Constitution documents of the applicant company, such as the certificate of incorporation or partnership deed
• No objection certificate (NOC) from the manufacturing unit owner agreeing to manufacture on a loan licence basis
• Site plan and layout of the manufacturing premises being used
• List of machinery and equipment available at the manufacturing unit
• Details of the technical staff, including a qualified pharmacist or technical director as required under the rules
• Product formulation details and master formula records for each drug to be manufactured
• Existing manufacturing licence of the licensor unit in Form 25 or Form 28, depending on the drug category
• Proof of address for both the applicant and the manufacturing premises

The manufacturing unit must already hold a valid licence for the category of drugs being produced, since a loan licence cannot be granted for products the licensor is not authorized to manufacture.

Step-by-Step Process to Obtain a Loan Licence

1. Identify a licensed manufacturer: Choose a pharmaceutical manufacturing unit that already holds a valid licence for the drug category you want to produce.
2. Sign a manufacturing agreement: Enter into a formal agreement with the manufacturer covering production terms, quality responsibility, and payment structure.
3. Prepare the application: File the application in the prescribed form, typically Form 24 or Form 27, along with the NOC from the manufacturer and supporting documents.
4. Submit to the State Drug Controller: Applications go to the Food and Drug Administration or State Drug Controller of the state where the manufacturing facility operates.
5. Facility inspection: A drug inspector visits the manufacturing site to verify that it meets Good Manufacturing Practices (GMP) as prescribed under Schedule M of the Drugs and Cosmetics Rules.
6. Query resolution: If the inspector raises observations about documentation, staffing, or facility standards, the applicant must respond with clarifications or corrective steps.
7. Licence grant: Once the authority is satisfied, it issues the loan licence, which is typically valid for five years and renewable thereafter.
8. Start production under supervision: Manufacturing begins under the technical supervision agreed upon in the contract, with the licensee responsible for quality and regulatory compliance of the branded product.

Common Mistakes and Practical Tips

Many first-time applicants choose a manufacturer without verifying whether the existing licence actually covers the specific drug category or dosage form they want to produce. Always cross-check the licensor's Form 25 or Form 28 scope before finalizing the agreement.

Some applicants underestimate the importance of a clear manufacturing agreement. Vague terms around quality responsibility or batch testing can create disputes later, so the contract should specify roles precisely.

Another frequent gap is inadequate documentation of the technical staff qualifications. Regulators expect a qualified pharmacist or technical director associated with the operation, and missing this detail is a common reason for delayed approvals.

A Real-World Scenario

A Delhi-based entrepreneur wanted to launch a range of ayurvedic supplements under his own brand but did not want to invest in a manufacturing plant immediately. He partnered with a GMP-certified manufacturer in Haryana holding the relevant licence, signed a manufacturing agreement, and applied for a loan licence. The State Drug Controller inspected the facility, verified documentation, and issued the licence within the standard processing timeline. This allowed the brand to launch products in the market while the entrepreneur planned his own facility for the following year.

How Corpzo Can Help

Applying for a loan licence involves coordinating agreements, verifying a manufacturer's existing licence scope, and preparing documentation that satisfies the State Drug Controller's requirements, and even a small gap in paperwork can stall the process for weeks.

Corpzo's team assists pharmaceutical entrepreneurs across India with loan licence applications, from identifying compliant manufacturing partners to preparing and filing the complete application. Reach out to Corpzo for guided support so your pharma brand can launch without unnecessary regulatory delays.